Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
3R35CA039903-03S2
Application #
3479235
Study Section
(SRC)
Project Start
1985-07-15
Project End
1992-06-30
Budget Start
1987-07-01
Budget End
1988-06-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Smith, Robert A; Loeb, Lawrence A; Preston, Bradley D (2005) Lethal mutagenesis of HIV. Virus Res 107:215-28
Shinkai, A; Patel, P H; Loeb, L A (2001) The conserved active site motif A of Escherichia coli DNA polymerase I is highly mutable. J Biol Chem 276:18836-42
Skandalis, A; Loeb, L A (2001) Enzymatic properties of rat DNA polymerase beta mutants obtained by randomized mutagenesis. Nucleic Acids Res 29:2418-26
Patel, P H; Kawate, H; Adman, E et al. (2001) A single highly mutable catalytic site amino acid is critical for DNA polymerase fidelity. J Biol Chem 276:5044-51
Patel, P H; Loeb, L A (2000) Multiple amino acid substitutions allow DNA polymerases to synthesize RNA. J Biol Chem 275:40266-72
Loeb, K R; Loeb, L A (2000) Significance of multiple mutations in cancer. Carcinogenesis 21:379-85
Patel, P H; Loeb, L A (2000) DNA polymerase active site is highly mutable: evolutionary consequences. Proc Natl Acad Sci U S A 97:5095-100
Silber, J R; Blank, A; Bobola, M S et al. (1999) O6-methylguanine-DNA methyltransferase-deficient phenotype in human gliomas: frequency and time to tumor progression after alkylating agent-based chemotherapy. Clin Cancer Res 5:807-14
Loeb, L A; Essigmann, J M; Kazazi, F et al. (1999) Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proc Natl Acad Sci U S A 96:1492-7
Encell, L P; Coates, M M; Loeb, L A (1998) Engineering human DNA alkyltransferases for gene therapy using random sequence mutagenesis. Cancer Res 58:1013-20

Showing the most recent 10 out of 103 publications